Urinary Branched-Chain Amino Acid Excretion and Chronic Kidney Disease Progression in Patients With Type 2 Diabetes

Restoration of branched-chain amino acid (BCAA) catabolism improves kidney pathology in animal models, but clinical data on the relationship between urinary BCAA excretion and kidney outcomes are scarce. Are urinary BCAA levels associated with CKD progression independent of clinical risk factors in patients with type 2 diabetes? High levels of urinary BCAAs predicted an increased risk of renal events independent of cardiorenal risk factors, with urinary MCP-1 mediating over 50% of the association. Activating intrarenal BCAA catabolism may potentially improve kidney function in patients with diabetes.

Authors

Institutions

Publication Details

Journal
Diabetes
Published
2025-11-21
DOI
https://doi.org/10.2337/db25-0782
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Urinary Branched-Chain Amino Acid Excretion and Chronic Kidney Disease Progression in Patients With Type 2 Diabetes

Ming Shen Tham, Huili Zheng, Keven Ang, Lye Siang Lee et al.
Diabetes
Chronic Kidney Disease and Diabetes
article

Urinary Branched-Chain Amino Acid Excretion and Chronic Kidney Disease Progression in Patients With Type 2 Diabetes

Ming Shen Tham, Huili Zheng, Keven Ang, Lye Siang Lee, Jian-Jun Liu, Janus Lee, Subrata Debnath, Thomas M. Coffman, Resham L Gurung, Jianhong Ching, Chrong‐Reen Wang, Su Chi Lim, Kumar Sharma, Sylvia Liu
article en

Abstract

Restoration of branched-chain amino acid (BCAA) catabolism improves kidney pathology in animal models, but clinical data on the relationship between urinary BCAA excretion and kidney outcomes are scarce. Are urinary BCAA levels associated with CKD progression independent of clinical risk factors in patients with type 2 diabetes? High levels of urinary BCAAs predicted an increased risk of renal events independent of cardiorenal risk factors, with urinary MCP-1 mediating over 50% of the association. Activating intrarenal BCAA catabolism may potentially improve kidney function in patients with diabetes.

DiabetesVol. 75(2)
National University of Singapore (SG), The University of Texas at San Antonio Health Science Center (US), Nanyang Technological University (SG), Khoo Teck Puat Hospital (SG), Precision for Medicine (United States) (US), National University Health System (SG), The University of Texas at San Antonio (US)
Openalex Percentile: Top 57%
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Urinary Branched-Chain Amino Acid Excretion and Chronic Kidney Disease Progression in Patients With Type 2 Diabetes — Ming Shen Tham, Huili Zheng, et al. · Diabetes (2025) | TGRS Research Map | TGRS